Cargando…
Comprehensive genomic analysis identifying heterogeneity in peripheral T‐cell lymphoma
Peripheral T‐cell lymphoma (PTCL) is a heterogeneous entity generally with a poor prognosis. Recent genomic analyses have characterized genomic alterations and described gene expression profiling and epigenetic mechanisms in PTCL, leading to reveal molecular pathophysiology in detail. One of several...
Autores principales: | Yoshida, Noriaki, Yamada, Kyohei, Ohshima, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019213/ https://www.ncbi.nlm.nih.gov/pubmed/33576080 http://dx.doi.org/10.1111/cas.14849 |
Ejemplares similares
-
Expression of telomerase reverse transcriptase in peripheral T‐cell lymphoma
por: Arakawa, Fumiko, et al.
Publicado: (2021) -
Identification of multiple subclones in peripheral T-cell lymphoma, not otherwise specified with genomic aberrations
por: Yoshida, Noriaki, et al.
Publicado: (2012) -
Clinical Applications of Genomic Alterations in ATLL: Predictive Markers and Therapeutic Targets
por: Yoshida, Noriaki, et al.
Publicado: (2021) -
STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomas
por: Yoshida, Noriaki, et al.
Publicado: (2015) -
Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)
por: Kawano, Noriaki, et al.
Publicado: (2019)